GNH USA

Europe — EMA

Omifin (Clomifene Citrate)

Clomifene citrate, the active ingredient in Omifin, is a selective estrogen receptor modulator presented as a tablet for oral use. It induces ovulation and is used in infertility treatment for women who do not ovulate…

Request sourcing

1
Pack/s

What is Clomifene Citrate?

Clomifene citrate, the active ingredient in Omifin, is a selective estrogen receptor modulator presented as a tablet for oral use. It induces ovulation and is used in infertility treatment for women who do not ovulate regularly.

GNH USA supplies Omifin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Clomifene Citrate used for?

Omifin is a selective estrogen receptor modulator that works within the reproductive hormone pathway to facilitate ovulation. - Anovulatory infertility: Helps ‑ women ‑ to achieve ovulation and improve pregnancy chances. - Polycystic ovary syndrome (PCOS): Assists ‑ women ‑ in restoring ‑ ovulatory cycles. - Assisted reproductive technology cycles: Supports ‑ women ‑ under ‑ controlled ovarian stimulation protocols. - Male infertility (off‑label): May ‑ increase ‑ testosterone ‑ levels, though evidence is limited.

What are the side effects of Clomifene Citrate?

Clomifene ​ ​      …  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Clomifene Citrate
Route
Oral Use
Manufacturer
Laboratorios Effik S.A.
Origin
EU

Related products